Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $ardx

Ardelyx (ARDX) sees a surge in social media buzz with engagements up significantly, driven by positive earnings reports and pipeline developments. However, concerns linger regarding XPHOZAH access.

### About $ardx
Ardelyx is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with chronic diseases.  

### Insights
- $ardx sentiment near a 52-week low at XX.
- $ardx posts created is up XXXXX% from the previous week.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ardx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ardx/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX +5.70%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-01-23  
1-Year Low: XX on 2025-09-24  

Engagements by network (24h):
Reddit: X
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ardx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ardx/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +27%  
X Months: XXXXX +11%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-01-06  
1-Year Low: X on 2025-09-22  

Mentions by network (24h):
Reddit: X
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ardx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ardx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $ardx in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX -XXXX%  
X Months: XXXXX +80%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-22  

The most influential creators that mention $ardx in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$ardx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ardx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ardx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-16  
1-Year Low: XX% on 2025-12-07  

Most Supportive Themes:
- Positive Earnings and Guidance: (30%) Ardelyx reported strong Q3 earnings, beating expectations with significant revenue growth for IBSRELA and raising full-year guidance. Analysts are positive, with some reiterating Buy ratings and price targets.
- Pipeline Development: (25%) Ardelyx announced the development of RDX10531, a next-generation NHE3 inhibitor, signaling a potential second growth wave with new intellectual property protection. This pipeline expansion is seen as a key long-term value driver.
- Analyst Upgrades and Positive Sentiment: (20%) Multiple analysts have issued positive ratings and price target increases for ARDX, citing strong sales performance and pipeline potential. Social media sentiment is largely bullish, with many posts highlighting the stock as a top gainer or a strong buy.
  
Most Critical Themes:
- XPHOZAH Access Challenges: (15%) Despite strong performance in other areas, there are ongoing concerns regarding reimbursement and access for XPHOZAH, which could impact future revenue and margins.
  

### Top $ardx Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Minervini "Trend Template" Screener πŸ“ˆ XX Stocks $NFGC $INBX $EYPT $BTE $CTRI $VIAV $SHOO $KLIC $NESR $PRM $FROG $SKE $ALGT $VICR $AAL $DGII $TE $SNDX $BKV $MDB $IAUX $ANAB $CNTA $BELFA $ZBIO $NUTX $APA $NUVL $FLNC $ATAT $DDS $FIVE $IHS $SITM $XPRO $BOOT $TTMI $UPWK $SMTC $LASR $BELFB $LILAK $INTC $UAL $ARDX $XPO $OCUL $USAS $PII $ELVN Criteria: Minervini Trend Template + Green Candle (Chg =0 Open Chg =0) + $1B+ Market Cap The market cap has been limited to $1B+ for liquidity purposes This screener is inspired by the eight criteria "Trend Template" described by the ever excellent Mark"  
[X Link](https://x.com/SteveDJacobs/status/1997285106277597670) [@SteveDJacobs](/creator/x/SteveDJacobs) 2025-12-06T12:40Z 7209 followers, 17K engagements


"$ARDX 🎯Target price Before the market closeπŸ”₯"  
[X Link](https://x.com/henkletrade/status/1997028736865370288) [@henkletrade](/creator/x/henkletrade) 2025-12-05T19:42Z XX followers, XX engagements


"$ARDX $ARE πŸ™‹β™‚ Guys Don't miss the next move in a few hours. πŸ“Šβž‘"  
[X Link](https://x.com/Molly_Keble/status/1996973266070917320) [@Molly_Keble](/creator/x/Molly_Keble) 2025-12-05T16:01Z XX followers, XXX engagements


"πŸ—ΎπŸ“˜πŸ‘›πŸ… Thanks to I followed his advice and entered the market at the right time which allowed me to earn $30000 in two days. #stock #MSFT $STOCK #IPO πŸ” $ARDX #Portfolio $VMI #Trading $CSPI #RealEstate 🀱 $HSBC"  
[X Link](https://x.com/GillandHul36997/status/1996948245524987961) [@GillandHul36997](/creator/x/GillandHul36997) 2025-12-05T14:22Z X followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ardx

Ardelyx (ARDX) sees a surge in social media buzz with engagements up significantly, driven by positive earnings reports and pipeline developments. However, concerns linger regarding XPHOZAH access.

About $ardx

Ardelyx is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with chronic diseases.

Insights

  • $ardx sentiment near a 52-week low at XX.
  • $ardx posts created is up XXXXX% from the previous week.

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +5.70%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-01-23
1-Year Low: XX on 2025-09-24

Engagements by network (24h): Reddit: X X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +27%
X Months: XXXXX +11%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-01-06
1-Year Low: X on 2025-09-22

Mentions by network (24h): Reddit: X X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $ardx in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XXXX%
X Months: XXXXX +80%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-22

The most influential creators that mention $ardx in the last XX hours

Creator Rank Followers Posts Engagements
@NightOwlBiotech X XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-16
1-Year Low: XX% on 2025-12-07

Most Supportive Themes:

  • Positive Earnings and Guidance: (30%) Ardelyx reported strong Q3 earnings, beating expectations with significant revenue growth for IBSRELA and raising full-year guidance. Analysts are positive, with some reiterating Buy ratings and price targets.
  • Pipeline Development: (25%) Ardelyx announced the development of RDX10531, a next-generation NHE3 inhibitor, signaling a potential second growth wave with new intellectual property protection. This pipeline expansion is seen as a key long-term value driver.
  • Analyst Upgrades and Positive Sentiment: (20%) Multiple analysts have issued positive ratings and price target increases for ARDX, citing strong sales performance and pipeline potential. Social media sentiment is largely bullish, with many posts highlighting the stock as a top gainer or a strong buy.

Most Critical Themes:

  • XPHOZAH Access Challenges: (15%) Despite strong performance in other areas, there are ongoing concerns regarding reimbursement and access for XPHOZAH, which could impact future revenue and margins.

Top $ardx Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Minervini "Trend Template" Screener πŸ“ˆ XX Stocks $NFGC $INBX $EYPT $BTE $CTRI $VIAV $SHOO $KLIC $NESR $PRM $FROG $SKE $ALGT $VICR $AAL $DGII $TE $SNDX $BKV $MDB $IAUX $ANAB $CNTA $BELFA $ZBIO $NUTX $APA $NUVL $FLNC $ATAT $DDS $FIVE $IHS $SITM $XPRO $BOOT $TTMI $UPWK $SMTC $LASR $BELFB $LILAK $INTC $UAL $ARDX $XPO $OCUL $USAS $PII $ELVN Criteria: Minervini Trend Template + Green Candle (Chg =0 Open Chg =0) + $1B+ Market Cap The market cap has been limited to $1B+ for liquidity purposes This screener is inspired by the eight criteria "Trend Template" described by the ever excellent Mark"
X Link @SteveDJacobs 2025-12-06T12:40Z 7209 followers, 17K engagements

"$ARDX 🎯Target price Before the market closeπŸ”₯"
X Link @henkletrade 2025-12-05T19:42Z XX followers, XX engagements

"$ARDX $ARE πŸ™‹β™‚ Guys Don't miss the next move in a few hours. πŸ“Šβž‘"
X Link @Molly_Keble 2025-12-05T16:01Z XX followers, XXX engagements

"πŸ—ΎπŸ“˜πŸ‘›πŸ… Thanks to I followed his advice and entered the market at the right time which allowed me to earn $30000 in two days. #stock #MSFT $STOCK #IPO πŸ” $ARDX #Portfolio $VMI #Trading $CSPI #RealEstate 🀱 $HSBC"
X Link @GillandHul36997 2025-12-05T14:22Z X followers, XX engagements

$ardx
/topic/$ardx